US index futures are higher after the cash open, pointing to a return of buying interest following the recent pullback. Sentiment is also supported by a constructive tone in equities outside the US. Nasdaq 100 futures are up more than 1%. The strongest risk-on signals are visible in financials, banks and the oil market, while within Big Tech the standout gainers are Nvidia and Amazon.

Source: xStation5
US100 has reacted twice to support at the 200-session exponential moving average (EMA200, red line) and is resuming its advance today. A move back above 25,500 points could indicate a more durable shift in sentiment toward a bullish bias.

Source: xStation5
Magnificent Seven - Nvidia clearly the strongest
-
Nvidia (NVDA.US): +1.7% – up after reports that Meta plans to deploy “millions” of Nvidia processors over the coming years, highlighting the accelerating scale of AI investment and strengthening ties between key players in the sector.
-
Amazon (AMZN.US): +1.6%
-
Microsoft (MSFT.US): +0.5%
-
Tesla (TSLA.US): +0.4%
-
Alphabet (GOOGL.US): +0.3%
-
Apple (AAPL.US): +0.2%
-
Meta Platforms (META.US): -0.5%
Top gainers
-
Global-e Online (GLBE.US): +24% – Q4 results beat expectations and guidance came in strong.
-
Rush Street (RSI.US): +20% – Q4 revenue and adjusted EBITDA topped consensus.
-
Mister Car Wash (MCW.US): +17% – Leonard Green & Partners to take the company private at $7 per share.
-
Wingstop (WING.US): +13% – solid results and US same-store sales growth above forecasts.
-
BioAge Labs (BIOA.US): +13% – upgraded to “buy”; investors are pricing in the potential of the company’s key therapy.
-
Verisk Analytics (VRSK.US): +11% – Q4 results exceeded expectations.
-
Madison Square Garden Sports (MSGS.US): +9% – the board approved a plan to evaluate a potential separation of the Knicks and Rangers businesses into two separately listed companies.
-
Moderna (MRNA.US): +8.1% – the FDA accepted for review an application related to a candidate seasonal flu vaccine.
-
Goosehead Insurance (GSHD.US): +7.8% – Q4 adjusted profit above consensus.
-
Constellium (CSTM.US): +6.8% – Q4 revenue up 28% YoY on strong demand in packaging and automotive.
-
Caesars Entertainment (CZR.US): +6% – better-than-expected “same-store” adjusted EBITDA.
-
Palantir (PLTR.US): +5% – upgraded following strong gains and improving margins.
-
Pitney Bowes (PBI.US): +5% – results beat forecasts and the 2026 outlook was strong.
-
Upwork (UPWK.US): +5% – announced a $300m share buyback program.
-
New York Times (NYT.US): +1.7% – shares rose after Berkshire Hathaway disclosed a position.
Top decliners
- Northern Dynasty Minerals (NAK.US): -34% – negative reaction after reports of US Department of Justice activity related to a federal case concerning the Pebble Project veto (Alaska).
-
SimilarWeb (SMWB.US): -21% – Q4 results missed expectations and guidance disappointed.
-
Axcelis Technologies (ACLS.US): -13% – weaker-than-expected Q1 guidance.
-
Palo Alto Networks (PANW.US): -7% – weaker guidance for Q3 and full-year adjusted profit.
-
MKS Instruments (MKSI.US): -6.7% – the market reacted negatively to results and the outlook.
-
ICL Group (ICL.US): -4.3% – Q4 profit and revenue below consensus.
-
Crocs (CROX.US): -1% – downgrade cited weakening domestic demand.
-
Workday (WDAY.US): -0.8% – downgraded to neutral.
Nvidia shares are up nearly 2% and have moved above the 50-session exponential moving average (EMA50), which suggests a return of bullish momentum.

Source: xStation5
Palantir gains 5% amid Mizuho upgrade
-
Upgrade from Mizuho: The bank raised its rating to Outperform from Neutral and maintained a $195 price target. The rationale: following a valuation “reset,” the risk/reward profile appears more attractive, with analysts describing the company as being in a category of its own.
-
Valuation backdrop: Despite last year’s AI-driven rally, the stock is still down roughly 25% in 2026, a move the market largely attributes to multiple compression.
-
Demand signal: Mizuho points to growing interest in the US commercial segment for Palantir’s AIP platform, alongside easing concerns about further multiple contraction after the earlier pullback.
-
Headquarters relocation: Palantir announced it has moved its headquarters to Miami from Denver, without providing additional details.
-
What investors are watching: Whether premarket gains will hold after the open — signaling fresh buying interest — or whether the move is driven primarily by short covering.
-
Risks: The company remains priced as a high-growth name; a slowdown in commercial wins or weaker government demand could renew pressure on the stock.

Source: xStation5
Gold surges 2.5% nearing $5000 per ounce ๐
Strong Quarter for Analog Devices and Record Outlook
WTI crude rises more than 3% ๐๐ฅ
Palo Alto earnings: Is security cheap now?
The material on this page does not constitute as financial advice and does not take into account your level of understanding, investment objectives, financial situation or any other particular needs.
All the information provided, including opinions, market research, mathematical results and technical analyses published on the website or transmitted to you by other means is provided for information purposes only and should in no event be interpreted as an offer of, or solicitation for, a transaction in any financial instrument, nor should the information provided be construed as advice of legal or fiscal nature.
Any investment decisions you make shall be based exclusively on your level of understanding, investment objectives, financial situation or any other particular needs. Any decision to act on information published on the website or transmitted to you by other means is entirely at your own risk. You are solely responsible for such decisions.
If you are in doubt or are not sure that you understand a particular product, instrument, service, or transaction, you should seek professional or legal advice before trading.
Investing in OTC Derivatives carries a high degree of risk, as they are leveraged based products and often small movements in the market could lead to much larger movements in the value of your investment and this could work against you or for you. Please ensure that you fully understand the risks involved, taking into account your investments objectives and level of experience, before trading, and if necessary, seek independent advice.